Skip to main content
S 1052 115th Congress Senate Health Drug safety, medical device, and laboratory regulation Health information and medical records Product development and innovation

BENEFIT Act of 2017

Introduced: May 4, 2017 Introduced by: Wicker, Roger F. Republican · Mississippi See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 11, 2017
Referred to the Subcommittee on Health.
Aug 4, 2017
Referred to the House Committee on Energy and Commerce.
Aug 4, 2017
Received in the House.
Aug 3, 2017
Message on Senate action sent to the House.
Aug 3, 2017
Passed Senate without amendment by Unanimous Consent. (text: CR S4788)
Aug 3, 2017
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(text: CR S4788)
Aug 3, 2017
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S4787-4788)
Aug 3, 2017
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.(consideration: CR S4787-4788)
May 4, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 4, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2017 or the BENEFIT Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to consider patient-focused drug development data, such as patient preferences, patient-reported outcomes, and patient experiences, as part of the risk-benefit assessment of new drugs. Following approval of a drug, the FDA must include a description of how this information was considered in its statement of patient experience.
What's happening now August 11, 2017

Referred to the Subcommittee on Health.

 Bill text 3 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 1
All 1 Democratic 1
D
Klobuchar, Amy
Minnesota · May 4, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1052: BENEFIT Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-S-1052/
MLA
"S. 1052: BENEFIT Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-1052/.
Bluebook (legal)
S. 1052, 115th Cong. (2026), https://openamerica.io/bill/115-S-1052/.
Markdown link
[S. 1052: BENEFIT Act of 2017](https://openamerica.io/bill/115-S-1052/)
Report a problem